Senior Director, Access Strategy & Marketing

About the role

The Senior Director of Access Strategy & Marketing will lead the development and execution of access strategy, non-clinical positioning, and marketing materials for the RevMed portfolio with a focus on NSCLC. As the RevMed portfolio grows, the Senior Director will build, coach and manage a team of Access Marketers. This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc) and channel partners. This role will be instrumental in supporting a successful launch through leading launch planning across Market Access function, tailored messaging to various customer types, and working cross-functionally with Brand Marketing, Medical/HEOR, Regulatory and Compliance partners. This role will require ability to educate and influence various senior-level stakeholders on Market Access strategy, key decisions and implications. The ideal candidate will also have experience in translating a dynamic policy and reimbursement landscape into access strategies over the product lifecycle (ie, impact of IRA, MFN, etc). This position is based out of our headquarters in Redwood City, CA. Remote candidates may be considered on case by case basis. Responsibilities may include: Develop and align with cross-functional partners on the three-year access strategy across RevMed's NSCLC portfolio. Lead and coach team of Access Marketers. Coordinate launch readiness efforts across Market Access team and represent Market Access in senior-level forums (i.e., cross-functional launch planning, labelling team, etc). Lead the creation of value proposition messaging and materials tailored for payers, PBMs, IDNs, GPOs, channel partners, and other key managed care decision-makers. Develop strong relationship with Medical Affairs to inform data strategy and evidence generation plan. Partner with national account field team to inform strategy and materials development. Work closely with Brand Marketing, Regulatory and Compliance to ensure all materials support brand goals and follow compliance guidelines. Required Skills, Experience and Education: Bachelor's degree required with 12+ years of experience in managed care strategy and marketing. Experience in new product launches, including both high level strategy development and tactical execution. Strong understanding of access landscape across all market access stakeholders. Prior experience with developing co-positioning strategy across multiple assets and identifying portfolio tradeoffs. Track record of being an inspiring leader and coach. Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines. Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication. Ability to travel up to 25%. Preferred Skills: 15+ years of experience in Marketing and/or Managed Care. Oral Oncolytic product experience strongly preferred. Deep understanding of US public policy and reimbursement dynamics. Prior experience working with lifecycle and regulatory teams. Prior experience in customer-facing roles. The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities. Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disabili

Benefits

Additional Information

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at revolutionmedicines? Share your experience